Hims & Hers Health, Inc. (NYSE:HIMS) Shares Sold by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky lessened its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) by 43.3% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 62,414 shares of the company's stock after selling 47,623 shares during the period. Teachers Retirement System of The State of Kentucky's holdings in Hims & Hers Health were worth $1,845,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently modified their holdings of the company. Summit Securities Group LLC acquired a new position in shares of Hims & Hers Health during the 4th quarter worth about $38,000. UMB Bank n.a. raised its position in shares of Hims & Hers Health by 247.5% during the 1st quarter. UMB Bank n.a. now owns 1,310 shares of the company's stock worth $39,000 after purchasing an additional 933 shares during the last quarter. Larson Financial Group LLC raised its position in shares of Hims & Hers Health by 47.7% during the 1st quarter. Larson Financial Group LLC now owns 1,419 shares of the company's stock worth $42,000 after purchasing an additional 458 shares during the last quarter. Fifth Third Bancorp raised its position in shares of Hims & Hers Health by 165.4% during the 1st quarter. Fifth Third Bancorp now owns 1,542 shares of the company's stock worth $46,000 after purchasing an additional 961 shares during the last quarter. Finally, Tsfg LLC acquired a new position in shares of Hims & Hers Health during the 1st quarter worth about $46,000. Institutional investors and hedge funds own 63.52% of the company's stock.

Insider Buying and Selling at Hims & Hers Health

In other Hims & Hers Health news, CFO Oluyemi Okupe sold 11,581 shares of the stock in a transaction that occurred on Monday, July 14th. The shares were sold at an average price of $47.70, for a total transaction of $552,413.70. Following the sale, the chief financial officer directly owned 54,084 shares in the company, valued at $2,579,806.80. This represents a 17.64% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Michael Chi sold 2,100 shares of the stock in a transaction that occurred on Thursday, July 24th. The stock was sold at an average price of $57.52, for a total transaction of $120,792.00. Following the sale, the insider owned 278,654 shares in the company, valued at approximately $16,028,178.08. This trade represents a 0.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 788,368 shares of company stock valued at $42,410,254 in the last quarter. Corporate insiders own 13.71% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HIMS. UBS Group set a $30.00 price objective on shares of Hims & Hers Health in a research note on Monday, June 23rd. Truist Financial upped their price objective on shares of Hims & Hers Health from $45.00 to $48.00 and gave the company a "hold" rating in a research note on Thursday, July 17th. TD Cowen cut shares of Hims & Hers Health from a "buy" rating to a "hold" rating and dropped their price target for the company from $44.00 to $30.00 in a research note on Tuesday, April 29th. Piper Sandler reissued a "neutral" rating and issued a $39.00 price target (up previously from $35.00) on shares of Hims & Hers Health in a research note on Tuesday, May 6th. Finally, Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Hims & Hers Health in a research note on Wednesday, May 7th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $39.83.

Hims & Hers Health Price Performance

Shares of NYSE:HIMS traded up $0.18 during mid-day trading on Friday, reaching $57.50. 46,302,225 shares of the company were exchanged, compared to its average volume of 30,801,588. The firm has a market cap of $12.87 billion, a price-to-earnings ratio of 83.33, a P/E/G ratio of 2.13 and a beta of 2.02. The firm's 50-day simple moving average is $53.15 and its 200 day simple moving average is $42.88. Hims & Hers Health, Inc. has a 1 year low of $13.47 and a 1 year high of $72.98.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.12 by $0.08. The firm had revenue of $586.01 million during the quarter, compared to analysts' expectations of $535.21 million. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The firm's quarterly revenue was up 110.7% on a year-over-year basis. During the same quarter last year, the company posted $0.05 EPS. On average, research analysts forecast that Hims & Hers Health, Inc. will post 0.29 earnings per share for the current fiscal year.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.